These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

182 related items for PubMed ID: 21985915

  • 1. Unsulfated cholecystokinin: An overlooked hormone?
    Rehfeld JF, Agersnap M.
    Regul Pept; 2012 Jan 10; 173(1-3):1-5. PubMed ID: 21985915
    [Abstract] [Full Text] [Related]

  • 2. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
    Béhé M, Behr TM.
    Biopolymers; 2002 Jan 10; 66(6):399-418. PubMed ID: 12658727
    [Abstract] [Full Text] [Related]

  • 3. Phylogeny of the cholecystokinin/gastrin family.
    Johnsen AH.
    Front Neuroendocrinol; 1998 Apr 10; 19(2):73-99. PubMed ID: 9578981
    [Abstract] [Full Text] [Related]

  • 4. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
    Behr TM, Béhé M, Angerstein C, Gratz S, Mach R, Hagemann L, Jenner N, Stiehler M, Frank-Raue K, Raue F, Becker W.
    Clin Cancer Res; 1999 Oct 10; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
    [Abstract] [Full Text] [Related]

  • 5. Nonsulfated cholecystokinins in the small intestine of pigs and rats.
    Agersnap M, Rehfeld JF.
    Peptides; 2015 Sep 10; 71():121-7. PubMed ID: 26206288
    [Abstract] [Full Text] [Related]

  • 6. The first nonsulfated sulfakinin activity reported suggests nsDSK acts in gut biology.
    Nichols R.
    Peptides; 2007 Apr 10; 28(4):767-73. PubMed ID: 17292511
    [Abstract] [Full Text] [Related]

  • 7. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones.
    Stone SR, Giragossian C, Mierke DF, Jackson GE.
    Peptides; 2007 Nov 10; 28(11):2211-22. PubMed ID: 17950490
    [Abstract] [Full Text] [Related]

  • 8. Evolution of gastrointestinal hormones: the cholecystokinin/gastrin family.
    Baldwin GS, Patel O, Shulkes A.
    Curr Opin Endocrinol Diabetes Obes; 2010 Feb 10; 17(1):77-88. PubMed ID: 19952740
    [Abstract] [Full Text] [Related]

  • 9. On the tissue-specific processing of procholecystokinin in the brain and gut--a short review.
    Rehfeld JF, Bungaard JR, Friis-Hansen L, Goetze JP.
    J Physiol Pharmacol; 2003 Dec 10; 54 Suppl 4():73-9. PubMed ID: 15075450
    [Abstract] [Full Text] [Related]

  • 10. Measurement of nonsulfated cholecystokinins.
    Agersnap M, Rehfeld JF.
    Scand J Clin Lab Invest; 2014 Aug 10; 74(5):424-31. PubMed ID: 24734780
    [Abstract] [Full Text] [Related]

  • 11. Characterization of two novel cholecystokinin tetrapeptide (30-33) analogues, A-71623 and A-70874, that exhibit high potency and selectivity for cholecystokinin-A receptors.
    Lin CW, Shiosaki K, Miller TR, Witte DG, Bianchi BR, Wolfram CA, Kopecka H, Craig R, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1991 Mar 10; 39(3):346-51. PubMed ID: 1706470
    [Abstract] [Full Text] [Related]

  • 12. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
    Behr TM, Jenner N, Béhé M, Angerstein C, Gratz S, Raue F, Becker W.
    J Nucl Med; 1999 Jun 10; 40(6):1029-44. PubMed ID: 10452322
    [Abstract] [Full Text] [Related]

  • 13. Conformationally readdressed CCK-B/delta-opioid peptide ligands.
    Nikiforovich GV, Kolodziej SA, Nock B, Bernad N, Martinez J, Marshall GR.
    Biopolymers; 1995 Oct 10; 36(4):439-52. PubMed ID: 7578939
    [Abstract] [Full Text] [Related]

  • 14. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
    Arlander SJ, Dong M, Ding XQ, Pinon DI, Miller LJ.
    Mol Pharmacol; 2004 Sep 10; 66(3):545-52. PubMed ID: 15322246
    [Abstract] [Full Text] [Related]

  • 15. Post-translational modifications of heterologously expressed cholecystokinin in Saccharomyces cerevisiae.
    Jønson L, Johnsen AH.
    Scand J Clin Lab Invest Suppl; 2001 Sep 10; 234():87-92. PubMed ID: 11713985
    [Abstract] [Full Text] [Related]

  • 16. Molecular and functional characterization of cionin receptors in the ascidian, Ciona intestinalis: the evolutionary origin of the vertebrate cholecystokinin/gastrin family.
    Sekiguchi T, Ogasawara M, Satake H.
    J Endocrinol; 2012 Apr 10; 213(1):99-106. PubMed ID: 22289502
    [Abstract] [Full Text] [Related]

  • 17. Distinct requirements for activation at CCK-A and CCK-B/gastrin receptors: studies with a C-terminal hydrazide analogue of cholecystokinin tetrapeptide (30-33).
    Lin CW, Holladay MW, Barrett RW, Wolfram CA, Miller TR, Witte D, Kerwin JF, Wagenaar F, Nadzan AM.
    Mol Pharmacol; 1989 Dec 10; 36(6):881-6. PubMed ID: 2601685
    [Abstract] [Full Text] [Related]

  • 18. CCK-A- and CCK-B-like receptors in the gallbladder and stomach of the alligator (Alligator mississippiensis).
    Oliver AS, Vigna SR.
    Gen Comp Endocrinol; 1997 Jan 10; 105(1):91-101. PubMed ID: 9000471
    [Abstract] [Full Text] [Related]

  • 19. The use of topographical constraints in receptor mapping: investigation of the topographical requirements of the tryptophan 30 residue for receptor binding of Asp-Tyr-D-Phe-Gly-Trp-(N-Me)Nle-Asp-Phe-NH2 (SNF 9007), a cholecystokinin (26-33) analogue that binds to both CCK-B and delta-opioid receptors.
    Boteju LW, Nikiforovich GV, Haskell-Luevano C, Fang SN, Zalewska T, Stropova D, Yamamura HI, Hruby VJ.
    J Med Chem; 1996 Sep 27; 39(20):4120-4. PubMed ID: 8831778
    [Abstract] [Full Text] [Related]

  • 20. The biology of cholecystokinin and gastrin peptides.
    Rehfeld JF, Friis-Hansen L, Goetze JP, Hansen TV.
    Curr Top Med Chem; 2007 Sep 27; 7(12):1154-65. PubMed ID: 17584137
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.